Thyroid Function of Pediatric Subjects Following Isovue® Administration

Summary

This is a Phase IV prospective, multicenter, observational study to estimate the proportion of subjects 0 to 3 years of age who develop abnormal thyroid function after exposure to intravascular administration of ISOVUE for the required radiologic procedure as part of their standard of care.

Timeline

Start

2019-03-26

Primary completion

2021-11-15

Completion

2022-03-25

Outcome

Outcome not reported

Stopped: “Formal release from PMR”

Drugs

Indications